Quantum Dot-Based Dual-Fluorescence Aptasensing Platform Using Interface-Engineered MXene for Multiplex Protein Detection
Sensors · 17.06.2026 · 26 (12) · 3856
DOI: 10.3390/s26123856 ↗Kurz gefasst
Fachartikel in der Zeitschrift Sensors, online erschienen am 17.06.2026. Verfasst von Qichen Yang und 12 weiteren Autor:innen. Beteiligte Einrichtung: School of Public Health, Inner Mongolia Medical University, Hohhot 010059, China. Hauptthemen laut MEDLINE: Quantum Dots, Biosensing Techniques, Aptamers, Nucleotide, Proteins. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Ministry of Science and Technology of the People's Republic of China, Tianjin Municipal Science and Technology Commission, State Key Laboratory of Pathogens and Biosecurity Independent.
Abstract (Originalsprache)
Antigen detection provides rapid and convenient diagnosis of respiratory infections. This study develops an innovative dual-fluorescence aptasensing method based on polydopamine-functionalized MXene (PDA-MXene) for the simultaneous detection of spike protein and hemagglutinin protein. The method employs green- and red-emitting quantum dot (QD) probes as fluorescence reporters, and the PDA-MXene as an effective adsorption and separation substrate. Coupled with a centrifugation-assisted separation strategy, this design method reduces background interference and enhances detection reliability. The method demonstrates good analytical performance, with detection limits of 0.82 ng/mL for spike protein and 2.11 ng/mL for hemagglutinin protein in single-channel mode. The dual-channel mode enables reliable and simultaneous quantification of both target proteins with minimal spectral cross-talk. Furthermore, this method exhibits high specificity against interferents including ions, proteins, and toxins. Artificial saliva, chosen as real sample, is spiked with target proteins to investigate the practical applicability of the method, showing recovery rates for both target proteins between 100 and 114 sensing strategy is simple to operate and allows the detection of new targets by simply replacing the azide-modified aptamer lyophilized powder. It therefore holds promising application for the simultaneous detection of multiple proteins in point-of-care testing and health monitoring fields.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Public Health, Inner Mongolia Medical University, Hohhot 010059, China.
- Tianjin Key Laboratory of Risk Assessment and Control Technology for Environment and Food Safety, Military Medical Sciences Academy, Academy of Military Sciences, Tianjin 300050, China.
Förderung
- The Ministry of Science and Technology of the People's Republic of China
- Tianjin Municipal Science and Technology Commission
- State Key Laboratory of Pathogens and Biosecurity Independent
- National Key Research and Development Program
- Natural Science Foundation of Tianjin
- State Key Laboratory of Pathogens and Biosecurity Independent Research Project
Zitieren
APA
Yang, Q., Yang, C., Liu, M., Su, N., Sun, J., Hou, J., Fu, Y., Wu, J., Wang, Y., Peng, Y., Bai, J., Liu, Y., & Zhao, Z. (2026). Quantum Dot-Based Dual-Fluorescence Aptasensing Platform Using Interface-Engineered MXene for Multiplex Protein Detection. Sensors, 26(12), 3856. https://doi.org/10.3390/s26123856
Vancouver
Yang Q, Yang C, Liu M, Su N, Sun J, Hou J, et al. Quantum Dot-Based Dual-Fluorescence Aptasensing Platform Using Interface-Engineered MXene for Multiplex Protein Detection. Sensors. 2026;26(12):3856. doi:10.3390/s26123856
BibTeX
@article{Yang2026,
author = {Yang, Qichen and Yang, Chun and Liu, Mingzhu and Su, Nan and Sun, Jingran and Hou, Jian and Fu, Yixue and Wu, Jin and Wang, Yu and Peng, Yuan and Bai, Jialei and Liu, Ying and Zhao, Zunquan},
title = {Quantum Dot-Based Dual-Fluorescence Aptasensing Platform Using Interface-Engineered MXene for Multiplex Protein Detection},
journal = {Sensors},
year = {2026},
volume = {26},
number = {12},
pages = {3856},
doi = {10.3390/s26123856}
}
EUVIMED